Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...

Atrial fibrillation (AF) is a major cause of morbidity and mortality globally, and much of this is driven by challenges in its timely diagnosis and treatment. Existing and emerging mobile technologies ...

Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia and cause of significant morbidity and mortality. Its increasing prevalence in aging societies constitutes a growing challenge to ...

“The findings of this study suggest that precardioversion monitoring using smartphone PPG represents an easy-to-use and highly scalable digital intervention that significantly reduced same-day ...

Atrial fibrillation (AF) is the most common heart rhythm disturbance and is associated with substantial morbidity and mortality. The overall prevalence of AF varies from 2% to 5% of the general ...

Anti-arrhythmic drugs should be used after successful cardioversion to reduce the risk of recurrent atrial fibrillation. 130,131 Ablation of the thyroid gland should be considered in case of recurrent ...

Advanced Methodologies in Multimodal, Multiorgan and Multiscale Biomedical Data Analysis ...